FORCES SHAPING THE AGRICULTURAL BIOTECHNOLOGY INDUSTRY: PATENTS, INSURANCE, REGULATION, AND FINANCING

1988 ◽  
Vol 17 (1) ◽  
pp. 169-180
Author(s):  
Beverly Fleisher
Author(s):  
James F. Oehmke ◽  
Anwar Naseem

AbstractThis article explores the relationships among mergers and acquisitions (M&A), consolidation, concentration and inventive activity in the agricultural biotechnology industry. We adapt testable hypotheses from the conceptual literature. We empirically test each hypothesis and interpret the results in terms of existing explanations of consolidation and the level of inventive activity, and antitrust policy. We find aggregate inventive activity to be related to M&A activity, but whether the effect is positive or negative is dependent on the type of M&A. Further, greater number of public sector firms in the research market, as well as increasing industry concentration, are both found to increase overall innovation.


2012 ◽  
Vol 58 (No. 6) ◽  
pp. 249-263
Author(s):  
M.-S. Lee

The study uses the fuzzy Delphi and FANP (fuzzy analysis network process) methods to integrate the views of experts from enterprises and academia regarding the future direction of the agricultural biotechnology industry in Taiwan, in order to extract the critical success factors influencing its transformation. This study compares the differences in the “cross-domain” and “non-cross-domain” critical success factors, and expects that the research results could be a decision-making reference for both the industry and the government. The research results show that the cross-domain critical factor that influence the transformation of the agricultural biotechnology industry in Taiwan are sequentially: a stable source of raw materials, control of the trend of market demand, a new production equipment, the capability in supporting upstream and downstream industries, the integration of the human resources of the upstream, midstream, and downstream industries, and the capability in marketing and promotion. The non-cross-domain critical factors are sequentially: the capacity to establish the system of product technology, the capacity to control intellectual property rights, a perfect educational system, the capacity to carry out risk management of the new product development, the competence in cultivating the capacity of technical and R&D personnel, and laws and regulations.  


1999 ◽  
Vol 4 (3) ◽  
pp. 1-13 ◽  
Author(s):  
Fred Buttel

This paper provides an overview of the recent development of the agricultural biotechnology sector and suggests what are likely to be some of the major issues in agrofood biotechnology in the future. I argue that while biotechnology has become increasingly entrenched as an approach to agrofood research and development, there are enormous public and especially corporate resources committed to biotechnology, and the growth of GMO market share in U.S. soybean, corn, and cotton production has been impressive, there has recently been growth of social resistance to biotechnology that casts the technology's and industry's future in some doubt. In addition to discussing the extent and limits of social resistance to biotechnology, I explore several other facets of agrofood biotechnology–global consolidation of the biotechnology industry, trade in GMO-produced food products, and the new corporate focus on “value-enhanced crops”–that will have a critical bearing on its future. I conclude by suggesting that while social resistance to agrofood biotechnology is very unlikely to derail the industry, public opposition will shape corporate strategy and could possibly shape research priorities in public biotechnology research.


Sign in / Sign up

Export Citation Format

Share Document